×
S&P 500   3,978.73 (+0.95%)
DOW   32,120.28 (+0.60%)
QQQ   288.75 (+0.53%)
AAPL   139.55 (-0.58%)
MSFT   261.75 (+0.82%)
FB   183.83 (+1.41%)
GOOGL   2,100.00 (-0.92%)
AMZN   2,123.17 (+1.98%)
TSLA   652.00 (+3.80%)
NVDA   153.60 (-4.92%)
BABA   82.20 (-0.33%)
NIO   14.64 (+0.07%)
AMD   90.79 (-0.41%)
CGC   5.03 (+5.67%)
MU   67.55 (+1.40%)
T   21.30 (+0.66%)
GE   74.15 (-0.50%)
F   12.71 (+2.33%)
DIS   103.26 (+1.64%)
AMC   11.55 (+11.16%)
PFE   53.73 (+0.60%)
PYPL   80.18 (+1.95%)
NFLX   187.06 (+3.73%)
S&P 500   3,978.73 (+0.95%)
DOW   32,120.28 (+0.60%)
QQQ   288.75 (+0.53%)
AAPL   139.55 (-0.58%)
MSFT   261.75 (+0.82%)
FB   183.83 (+1.41%)
GOOGL   2,100.00 (-0.92%)
AMZN   2,123.17 (+1.98%)
TSLA   652.00 (+3.80%)
NVDA   153.60 (-4.92%)
BABA   82.20 (-0.33%)
NIO   14.64 (+0.07%)
AMD   90.79 (-0.41%)
CGC   5.03 (+5.67%)
MU   67.55 (+1.40%)
T   21.30 (+0.66%)
GE   74.15 (-0.50%)
F   12.71 (+2.33%)
DIS   103.26 (+1.64%)
AMC   11.55 (+11.16%)
PFE   53.73 (+0.60%)
PYPL   80.18 (+1.95%)
NFLX   187.06 (+3.73%)
S&P 500   3,978.73 (+0.95%)
DOW   32,120.28 (+0.60%)
QQQ   288.75 (+0.53%)
AAPL   139.55 (-0.58%)
MSFT   261.75 (+0.82%)
FB   183.83 (+1.41%)
GOOGL   2,100.00 (-0.92%)
AMZN   2,123.17 (+1.98%)
TSLA   652.00 (+3.80%)
NVDA   153.60 (-4.92%)
BABA   82.20 (-0.33%)
NIO   14.64 (+0.07%)
AMD   90.79 (-0.41%)
CGC   5.03 (+5.67%)
MU   67.55 (+1.40%)
T   21.30 (+0.66%)
GE   74.15 (-0.50%)
F   12.71 (+2.33%)
DIS   103.26 (+1.64%)
AMC   11.55 (+11.16%)
PFE   53.73 (+0.60%)
PYPL   80.18 (+1.95%)
NFLX   187.06 (+3.73%)
S&P 500   3,978.73 (+0.95%)
DOW   32,120.28 (+0.60%)
QQQ   288.75 (+0.53%)
AAPL   139.55 (-0.58%)
MSFT   261.75 (+0.82%)
FB   183.83 (+1.41%)
GOOGL   2,100.00 (-0.92%)
AMZN   2,123.17 (+1.98%)
TSLA   652.00 (+3.80%)
NVDA   153.60 (-4.92%)
BABA   82.20 (-0.33%)
NIO   14.64 (+0.07%)
AMD   90.79 (-0.41%)
CGC   5.03 (+5.67%)
MU   67.55 (+1.40%)
T   21.30 (+0.66%)
GE   74.15 (-0.50%)
F   12.71 (+2.33%)
DIS   103.26 (+1.64%)
AMC   11.55 (+11.16%)
PFE   53.73 (+0.60%)
PYPL   80.18 (+1.95%)
NFLX   187.06 (+3.73%)
LON:IDEA

Ideagen (IDEA) Share Forecast, Price & News

GBX 345.75
+0.75 (+0.22%)
(As of 05/25/2022 11:11 AM ET)
Add
Compare
Today's Range
344.70
346.50
50-Day Range
212
355.94
52-Week Range
195
360
Volume
5.54 million shs
Average Volume
2.36 million shs
Market Capitalization
£1.02 billion
P/E Ratio
172.88
Dividend Yield
0.11%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive IDEA News and Ratings via Email

Sign-up to receive the latest news and ratings for Ideagen and its competitors with MarketBeat's FREE daily newsletter.

Ideagen logo

About Ideagen

Ideagen plc develops and sells information management software in the United Kingdom, the United States, Europe, and internationally. Its governance, risk, and compliance (GRC) solutions include Q-Pulse QMS, a quality management software; Q-Pulse PM, a product management software; Q-Pulse Law, an EHS legal compliance software; Q-Pulse WorkRite, a health and safety management system; Pentana Audit, an audit automation software; Pentana Disclose, a financial disclosure checklist software; Pentana Compliance, an accountability and competency compliance software; and Pentana Risk, a cloud-based performance and risk management software. The company's GRC solutions also comprise Coruson, an enterprise cloud-based safety management software; PleaseReview, a document review, co-authoring, and redaction software; and Ideagen Academy, a cloud-based E-learning solution. It serves the aerospace and defense, accounting, finance and banking, construction, aviation, energy, food and drink, healthcare, life science, and manufacturing industries. The company was formerly known as Datum International Plc and changed its name to Ideagen plc in July 2011. Ideagen plc was incorporated in 1993 and is headquartered in Ruddington, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Technical & System Software
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
697
Year Founded
N/A

Sales & Book Value

Annual Sales
£75.28 million
Cash Flow
GBX 20.51 per share
Book Value
GBX 52.90 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£1.02 billion
Optionable
Not Optionable

Company Calendar

Ex-Dividend for 3/17 Dividend
2/24/2022
Dividend Payable
3/17/2022
Today
5/25/2022
Next Earnings (Estimated)
7/20/2022

MarketRank

Overall MarketRank

1.35 out of 5 stars

Analyst Opinion: 1.5Community Rank: 3.6Dividend Strength: 0.8Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -













Ideagen (LON:IDEA) Frequently Asked Questions

Is Ideagen a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ideagen in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Ideagen stock.
View analyst ratings for Ideagen
or view top-rated stocks.

When is Ideagen's next earnings date?

Ideagen is scheduled to release its next quarterly earnings announcement on Wednesday, July 20th 2022.
View our earnings forecast for Ideagen
.

How often does Ideagen pay dividends? What is the dividend yield for Ideagen?

Ideagen declared a dividend on Thursday, January 13th. Investors of record on Thursday, February 24th will be given a dividend of GBX 0.14 per share on Thursday, March 17th. This represents a dividend yield of 0.05%. The ex-dividend date is Thursday, February 24th. The official announcement can be accessed at this link.
View Ideagen's dividend history
.

Is Ideagen a good dividend stock?

Ideagen pays an annual dividend of GBX 0 per share and currently has a dividend yield of 0.11%. The dividend payout ratio of Ideagen is 0.19%. This payout ratio is at a healthy, sustainable level, below 75%.
View Ideagen's dividend history.

What price target have analysts set for IDEA?

2 analysts have issued 12-month target prices for Ideagen's shares. Their forecasts range from GBX 365 to GBX 365. On average, they anticipate Ideagen's share price to reach GBX 365 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price.
View analysts' price targets for Ideagen
or view top-rated stocks among Wall Street analysts.

Who are Ideagen's key executives?
Ideagen's management team includes the following people:
  • Mr. Benjamin Charles Dorks, CEO & Director (Age 47, Pay $335k)
  • Ms. Emma Jane Hayes, CFO & Director (Age 41, Pay $217.2k)
  • Mr. Leslie D. Paul, Founder (Age 63)
  • Ms. Louise Tommasi, Chief People Officer
  • Paul Marshall, Chief Customer Officer
  • Mr. James King, Chief Revenue Officer (Age 50)
  • David Moore, Chief Product Officer
What other stocks do shareholders of Ideagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ideagen investors own include Sirius Minerals (SXX), Fevertree Drinks (FEVR), Flowgroup (FLOW), RPC Group (RPC), Gulf Keystone Petroleum (GKP), Merlin Entertainments (MERL), Plutus PowerGen (PPG), Amino Technologies (AMO), Bowleven (BLVN) and BP (BP).

What is Ideagen's stock symbol?

Ideagen trades on the London Stock Exchange (LON) under the ticker symbol "IDEA."

How do I buy shares of Ideagen?

Shares of IDEA and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Ideagen's stock price today?

One share of IDEA stock can currently be purchased for approximately GBX 345.75.

How much money does Ideagen make?

Ideagen has a market capitalization of £1.02 billion and generates £75.28 million in revenue each year.

How many employees does Ideagen have?

Ideagen employs 697 workers across the globe.

What is Ideagen's official website?

The official website for Ideagen is www.ideagen.com.

How can I contact Ideagen?

Ideagen's mailing address is 11710 Plaza America Drive Suite 2000 Reston VA 20190 United States. The company can be reached via phone at +1 (202) 888 3560.

This page was last updated on 5/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.